Cardiovascular Insufficiency Clinical Trial
— PLR-ANSOfficial title:
Passive Leg Raising - an Important Diagnostic Manoeuvre and Its Dependency on the Activity of the Autonomous Nervous System in Critically Ill Patients and Healthy Subjects
Verified date | September 2021 |
Source | Region MidtJylland Denmark |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim is to describe the physiological background for PLR and the interpretation of a PLR manoeuvre. The protocol entails the measurement of stroke volume (SV) at baseline (semirecumbent patient position), during PLR and after returning to semirecumbent position. Simultaneously blood pressure (BP), pulse rate (PR), pulse oximetric saturation (SpO2) and ECG are recorded. The procedure is performed in ten normal subjects, ten patients recruited in the cardiology outpatient department and ten critically ill patients under analgosedation in the ICU. Analysis includes changes in measured variables and heart rate variability in the frequency domain during the three phases of the experiment.
Status | Completed |
Enrollment | 11 |
Est. completion date | October 1, 2020 |
Est. primary completion date | October 1, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: Consenting after written and oral information Exclusion Criteria: Contraindications to PLR: intracranial or abdominal hypertension |
Country | Name | City | State |
---|---|---|---|
Denmark | Regionshospitalet Silkeborg | Silkeborg | Midtjylland |
Lead Sponsor | Collaborator |
---|---|
Region MidtJylland Denmark | Edwards Lifesciences |
Denmark,
Monnet X, Rienzo M, Osman D, Anguel N, Richard C, Pinsky MR, Teboul JL. Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med. 2006 May;34(5):1402-7. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in cardiovascular variables I | stroke volume, SV (mL) | 10 minutes | |
Primary | Changes in cardiovascular variables II | pulse rate, PR (min^-1) | 10 minutes | |
Primary | Changes in cardiovascular variables III | blood pressure, BP (mmHg) | 10 minutes | |
Primary | Changes in cardiovascular variables IV | pulse oximetric saturation, SpO2 (%) | 10 minutes | |
Primary | Changes in HRV frequency domain variables V | Heart rate variability, HRV, variables in frequency domain (low frequency, LF, 0.04-0.15 Hz, high frequency, HF, 0.15-0.4 Hz) | 10 minutes | |
Primary | Changes in HRV frequency domain variables VI | HRV absolute power (ms^2, natural logarithm transformed values of absolute powers of very low frequency, VLF, LF, and HF bands) | 10 minutes | |
Primary | Changes in HRV frequency domain variables VII | HRV relative power (absolute power/total power) | 10 minutes | |
Primary | Changes in HRV frequency domain variables VIII | HRV normalized power (%, normalized units, n.u.) | 10 minutes | |
Primary | Changes in HRV frequency domain variables IX | HRV total power given by VLF + HF + LF (ms2) and LF/HF ratio. | 10 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03882580 -
Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
|
||
Completed |
NCT01954056 -
Hydrocortisone for Term Hypotension
|
Phase 3 | |
Completed |
NCT05828407 -
Fluid Challenge Impact in the Portal Vein Pulsatility Depending on the Fluid Responsivness Status
|
||
Terminated |
NCT04086953 -
Validation of a Walk-Time Limit Test (WTLT) Derived From the 6-Minute Walk Test (6-MWT) in Patients With Chronic Cardiovascular or Respiratory Diseases
|
N/A |